MedTrace Logo

The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients

NCT07244731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2025-11-24

No results posted yet for this study

Summary

The aim of this study was to evaluate the prognostic significance of erythrocyte distribution width (RDW) in severe and critically ill COVID-19 patients followed in the intensive care unit (ICU). RDW is a parameter that measures the heterogeneity in red blood cell size and is associated with the pathophysiological processes of COVID-19, such as systemic inflammation, oxidative stress, and erythropoiesis disorders. This study investigated the relationship between RDW and the need for intubation and mortality, and its utility as a prognostic marker in COVID-19 patients.

Conditions

  • COVID - 19
  • Prognosis
  • ICU

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Mustafa Necmettin Ünal · Ankara University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07244731 on ClinicalTrials.gov